Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Timing Is Everything: Merck Begins Payment Disclosures With 3rd Quarter

Executive Summary

Merck picked a good time to begin its move into the new world of public disclosure of payments to health care providers

You may also be interested in...



Sunshine Act Hits Daylight Savings Time; PhRMA Seeks Extension For Physician Payment Reporting

Industry groups have asked HHS Secretary Kathleen Sebelius to give companies additional time to collect and report their payments to physicians and teaching hospitals since HHS has yet to establish the procedures for doing so.

Sunshine Act Hits Daylight Savings Time; PhRMA Seeks Extension For Physician Payment Reporting

Industry groups have asked HHS Secretary Kathleen Sebelius to give companies additional time to collect and report their payments to physicians and teaching hospitals since HHS has yet to establish the procedures for doing so.

Reform's "Sunshine" Clause Prompts Firms To Review Disclosure Web Sites

Any drug, device or medical supply company that sells products to a government program and provides payments or items worth more than $10 to practicing physicians or teaching hospitals will be required to post those outlays in a publicly-available database starting in 2013

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS051619

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel